Skip to main content

Peer Review reports

From: Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

Original Submission
16 Nov 2006 Submitted Original manuscript
21 Mar 2007 Author responded Author comments - Yaewon Yang
4 Dec 2006 Reviewed Reviewer Report - Shinichi Tsutsui
18 Jan 2007 Reviewed Reviewer Report - Peter Sinn
Resubmission - Version 2
21 Mar 2007 Submitted Manuscript version 2
10 Apr 2007 Author responded Author comments - Yaewon Yang
23 Mar 2007 Reviewed Reviewer Report - Shinichi Tsutsui
4 Apr 2007 Reviewed Reviewer Report - Peter Sinn
Resubmission - Version 3
10 Apr 2007 Submitted Manuscript version 3
11 Apr 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 4
11 Apr 2007 Submitted Manuscript version 4
Publishing
12 Apr 2007 Editorially accepted
12 Apr 2007 Article published 10.1186/1471-2407-7-63

You can find further information about peer review here.

Back to article page
\